The Correlations of Plasma Liver-Type Fatty Acid-Binding Protein with Amyloid-β and Tau Levels in Patients with Alzheimer's Disease

被引:5
作者
Cheng, Yuan [1 ,2 ,4 ]
Jian, Jie-Ming [1 ,2 ,4 ]
He, Chen-Yang [1 ,2 ,4 ]
Ren, Jun-Rong [1 ,2 ,4 ]
Xu, Man-Yu [1 ,2 ,4 ]
Jin, Wang-Sheng [1 ,2 ,4 ]
Tan, Cheng-Rong [1 ,2 ,4 ]
Zeng, Gui-Hua [1 ,2 ,4 ]
Shen, Ying-Ying [1 ,2 ,4 ]
Chen, Dong-Wan [1 ,2 ,4 ]
Li, Hui-Yun [1 ,2 ,4 ]
Yi, Xu [1 ,2 ,4 ]
Zhang, Yuan [1 ,2 ,4 ]
Zeng, Fan [1 ,2 ,4 ]
Wang, Yan-Jiang [1 ,2 ,3 ,4 ,5 ]
机构
[1] Third Mil Med Univ, Daping Hosp, Dept Neurol, Chongqing, Peoples R China
[2] Third Mil Med Univ, Daping Hosp, Ctr Clin Neurosci, Chongqing, Peoples R China
[3] Third Mil Med Univ, Inst Brain & Intelligence, Chongqing, Peoples R China
[4] Chongqing Key Lab Ageing & Brain Dis, Chongqing, Peoples R China
[5] Chinese Acad Sci, Ctr Excellence Brain Sci & Intelligence Technol, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; amyloid-beta; liver-type fatty acid-binding protein; tau; A-BETA; DEMENTIA; SERUM; CHOLESTEROL; METABOLISM; MARKER; RISK; GENE;
D O I
10.3233/JAD-220126
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: The dysregulation of lipid metabolism plays an important role in the pathogenesis of Alzheimer's disease (AD). Liver-type fatty acid-binding protein (L-FABP, also known as FABP1) is critical for fatty acid transport and may be involved in AD. Objective: To investigate whether the FABP1 level is altered in patients with AD, and its associations with levels of amyloid-beta (A beta) and tau in the plasma and cerebrospinal fluid (CSF). Methods: A cross-sectional study was conducted in a Chinese cohort consisting of 39 cognitively normal controls and 47 patients with AD. The levels of FABP1 in plasma, and A beta and tau in CSF, were measured by enzyme-linked immunosorbent assay (ELISA). A single-molecule array (SIMOA) was used to detect plasma A beta levels. Results: The level of plasma FABP1 was significantly elevated in the AD group (p = 0.0109). Further analysis showed a positive correlation of FABP1 with CSF total tau (t-tau) and phosphorylated tau (p-tau) levels. Besides, plasma FABP1/A beta(42) (AUC= 0.6794, p = 0.0071) and FABP1/t-tau (AUC= 0.7168, p = 0.0011) showed fair diagnostic efficacy for AD. When combined with other common AD biomarkers including plasma A beta(42), A beta(40), and t-tau, both FABP1/A beta(42) and FABP1/t-tau showed better diagnostic efficacy than using these biomarkers alone. Among all AUC analyses, the combination of plasma FABP1/t-tau and A beta(42) had the highest diagnostic value (AUC= 0.8075, p < 0.0001). Conclusion: These findings indicate that FABP1 may play a role in AD pathogenesis and be worthy of further investigation in the future.
引用
收藏
页码:375 / 383
页数:9
相关论文
共 32 条
[1]   Is Alzheimer's Disease a Liver Disease of the Brain? [J].
Bassendine, Margaret F. ;
Taylor-Robinson, Simon D. ;
Fertleman, Michael ;
Khan, Michael ;
Neely, Dermot .
JOURNAL OF ALZHEIMERS DISEASE, 2020, 75 (01) :1-14
[2]   Impact of Fatty Acid-Binding Proteins in α-Synuclein-Induced Mitochondrial Injury in Synucleinopathy [J].
Cheng, An ;
Jia, Wenbin ;
Kawahata, Ichiro ;
Fukunaga, Kohji .
BIOMEDICINES, 2021, 9 (05)
[3]   Fatty Acid Metabolism in Carriers of Apolipoprotein E Epsilon 4 Allele: Is It Contributing to Higher Risk of Cognitive Decline and Coronary Heart Disease? [J].
Chouinard-Watkins, Raphael ;
Plourde, Melanie .
NUTRIENTS, 2014, 6 (10) :4452-4471
[4]   Apo lipoprotein E isoforms disrupt long-chain fatty acid distribution in the plasma, the liver and the adipose tissue of mice [J].
Conway, Valerie ;
Larouche, Annie ;
Alata, Wael ;
Vandal, Milene ;
Calon, Frederic ;
Plourde, Melanie .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2014, 91 (06) :261-267
[5]   Heart fatty acid binding protein and Aβ-associated Alzheimer's neurodegeneration [J].
Desikan, Rahul S. ;
Thompson, Wesley K. ;
Holland, Dominic ;
Hess, Christopher P. ;
Brewer, James B. ;
Zetterberg, Henrik ;
Blennow, Kaj ;
Andreassen, Ole A. ;
McEvoy, Linda K. ;
Hyman, Bradley T. ;
Dale, Anders M. .
MOLECULAR NEURODEGENERATION, 2013, 8
[6]   The Role of Elevated Liver-Type Fatty Acid-Binding Proteins in Liver Diseases [J].
Eguchi, Akiko ;
Iwasa, Motoh .
PHARMACEUTICAL RESEARCH, 2021, 38 (01) :89-95
[7]   Serum Liver-Type Fatty Acid-Binding Protein Is a Possible Prognostic Factor in Human Chronic Liver Diseases From Chronic Hepatitis to Liver Cirrhosis and Hepatocellular Carcinoma [J].
Eguchi, Akiko ;
Hasegawa, Hiroshi ;
Iwasa, Motoh ;
Tamai, Yasuyuki ;
Ohata, Keiichi ;
Oikawa, Tsuyoshi ;
Sugaya, Takeshi ;
Takei, Yoshiyuki .
HEPATOLOGY COMMUNICATIONS, 2019, 3 (06) :825-837
[8]   Neural stem cells and adult brain fatty acid metabolism: Lessons from the 3xTg model of Alzheimer's disease [J].
Hamilton, Laura K. ;
Fernandes, Karl J. L. .
BIOLOGY OF THE CELL, 2018, 110 (01) :6-25
[9]   Aberrant Lipid Metabolism in the Forebrain Niche Suppresses Adult Neural Stem Cell Proliferation in an Animal Model of Alzheimer's Disease [J].
Hamilton, Laura K. ;
Dufresne, Martin ;
Joppe, Sandra E. ;
Petryszyn, Sarah ;
Aumont, Anne ;
Calon, Frederic ;
Barnabe-Heider, Fanie ;
Furtos, Alexandra ;
Parent, Martin ;
Chaurand, Pierre ;
Fernandes, Karl J. L. .
CELL STEM CELL, 2015, 17 (04) :397-411
[10]   CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts [J].
Hansson, Oskar ;
Seibyl, John ;
Stomrud, Erik ;
Zetterberg, Henrik ;
Trojanowski, John Q. ;
Bittner, Tobias ;
Lifke, Valeria ;
Corradini, Veronika ;
Eichenlaub, Udo ;
Batrla, Richard ;
Buck, Katharina ;
Zink, Katharina ;
Rabe, Christina ;
Blennow, Kaj ;
Shaw, Leslie M. .
ALZHEIMERS & DEMENTIA, 2018, 14 (11) :1470-1481